BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 27659705)

  • 1. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
    Coleman BM; Hill AF
    Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteins.
    Cheng L; Zhao W; Hill AF
    Mol Aspects Med; 2018 Apr; 60():62-68. PubMed ID: 29196098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles - propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases.
    Vassileff N; Cheng L; Hill AF
    J Cell Sci; 2020 Dec; 133(23):. PubMed ID: 33310868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease.
    Vella LJ; Hill AF; Cheng L
    Int J Mol Sci; 2016 Feb; 17(2):173. PubMed ID: 26861304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration.
    Bellingham SA; Guo B; Hill AF
    Biol Cell; 2015 Nov; 107(11):389-418. PubMed ID: 26032945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.
    Cherry P; Gilch S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?
    Bellingham SA; Guo BB; Coleman BM; Hill AF
    Front Physiol; 2012; 3():124. PubMed ID: 22563321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions on the run: How extracellular vesicles serve as delivery vehicles for self-templating protein aggregates.
    Liu S; Hossinger A; Göbbels S; Vorberg IM
    Prion; 2017 Mar; 11(2):98-112. PubMed ID: 28402718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
    Grad LI; Fernando SM; Cashman NR
    Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration.
    Belkozhayev AM; Al-Yozbaki M; George A; Ye Niyazova R; Sharipov KO; Byrne LJ; Wilson CM
    Curr Neuropharmacol; 2022; 20(8):1450-1478. PubMed ID: 34414870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.